ALPS
ALPS
NASDAQ · Biotechnology

Alps Group Inc

$1.01
+0.01 (+1.00%)
As of Apr 1, 10:08 PM ET ·
Financial Highlights (FY 2025)
Revenue
44.46M
Net Income
5.47M
Gross Margin
49.9%
Profit Margin
12.3%
Rev Growth
+4.4%
D/E Ratio
0.49
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 49.9% 49.9% 49.9%
Operating Margin 14.6% 12.4% 13.6%
Profit Margin 12.3% 11.1% 13.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 44.46M 45.50M 43.44M
Gross Profit 22.20M 22.72M 21.69M
Operating Income 6.50M 5.66M 5.92M
Net Income 5.47M 5.03M 5.89M
Gross Margin 49.9% 49.9% 49.9%
Operating Margin 14.6% 12.4% 13.6%
Profit Margin 12.3% 11.1% 13.6%
Rev Growth +4.4% +9.5% -0.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 47.60M 48.53M 40.38M
Total Equity 97.85M 101.23M 97.37M
D/E Ratio 0.49 0.48 0.41
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.24M 9.46M 8.95M
Free Cash Flow 4.73M 3.67M 4.46M